
==== Front
VideoGIE
VideoGIE
VideoGIE
2468-4481
Elsevier

S2468-4481(24)00076-6
10.1016/j.vgie.2024.05.004
Original Article
Addition of dilute epinephrine to commercially available submucosal lifting agents for cold snare EMR
Hirsch William MD 1
McDonald Nicholas MD 2
Cintron Roberto Osorio RN 3
Bilal Mohammad MD 45
1 Division of Internal Medicine, Department of Medicine, University of Minnesota, Minneapolis, Minnesota
2 Division of Gastroenterology, Hepatology, and Nutrition, University of Minnesota Medical Center, Minneapolis, Minnesota
3 Division of Gastroenterology and Hepatology, Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota
4 Division of Gastroenterology, Hepatology, and Nutrition, University of Minnesota Medical Center, Minneapolis, Minnesota
5 Division of Gastroenterology and Hepatology, Minneapolis Veterans Affairs Medical Center, Minneapolis, Minnesota
09 5 2024
8 2024
09 5 2024
9 8 382384
© 2024 American Society for Gastrointestinal Endoscopy. Published by Elsevier Inc.
2024
American Society for Gastrointestinal Endoscopy
https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Graphical Abstract

Abbreviation

cs-EMR cold snare EMR
==== Body
pmcIntroduction

The European Society of Gastrointestinal Endoscopy recommends that duodenal adenomas be considered for management with EMR.1 In recent years, there has been an increase in use of cold snare EMR (cs-EMR) for removal of colon polyps and nonampullary duodenal polyps.2 cs-EMR avoids the use of electrocautery for resecting polyps, and therefore leads to reduced risk of delayed bleeding and perforation.3 Several experts suggest adding dilute epinephrine to the submucosal injectate solution to reduce intraprocedural oozing, which improves visualization during resection.

The addition of dilute epinephrine while performing EMR has been well-described due to its benefit of reducing intraprocedural oozing and helping visualization during resection; however, data around its use are limited, and the addition of epinephrine to commercially available lifting solutions has not been well characterized.4, 5, 6 One meta-analysis found that use of viscous and hypertonic lifting solutions leads to higher rates of en bloc resection and lower rates of residual lesion compared with use of normal saline as a lifting solution for EMR.7 In this video, we detail the case of a patient referred for endoscopic resection of a duodenal adenoma. Here, we describe the preparation and clinical application of a commercially available lifting solution mixed with dilute epinephrine to aid in the successful cs-EMR of a duodenal adenoma (Video 1, available online at www.videogie.org).

Technique

Required supplies including a commercially available lifting agent, 0.1 mg/mL epinephrine syringe (epinephrine 1:10,000), a 25-gauge needle, 10 mL of normal saline, and a 3-way stopcock were gathered (Fig. 1A).Figure 1 A, Required supplies for creation of dilute epinephrine lifting solution injectate. B, Final mixing of the submucosal injectate using 3-way stopcock prior to use during endoscopy.

First, a 25-gauge needle was attached to the epinephrine 1:10,000 syringe. Next, 1 mL from the normal saline syringe was wasted. Then, 1 mL of epinephrine 1:10,000 was added to the normal saline flush to replace the 1 mL of saline that had been wasted. A total of 1 mL of the commercially available lifting agent was then wasted. A total of 1 mL of the dilute epinephrine solution was then added to the commercially available lifting agent to replace the 1 mL that had been wasted. An empty flush was then attached to the combined lifting agent and dilute epinephrine before being mixed using a 3-way stopcock (Fig. 1B).

Case Presentation

A 73-year-old man was referred after identification of a duodenal adenoma on EGD for abdominal pain. EGD was performed, and the duodenal adenoma was identified (Fig. 2A). During EGD, the prepared submucosal injectate solution was used to lift the duodenal adenoma in preparation for cs-EMR (Fig. 2B).Figure 2 A, Duodenal adenoma (arrow) visualized on EGD. B, Duodenal adenoma (arrow) being lifted using the prepared submucosal injectate with dilute epinephrine mixture.

Piecemeal resection of the duodenal adenoma was then performed using cs-EMR. Despite the highly vascularized nature of the duodenum, there was minimal bleeding due to the addition of epinephrine to the commercially available lifting agent (Fig. 3A). The area of defect was subsequently examined using water immersion without evidence of residual adenoma or bleeding (Fig. 3B). The defect was not closed in line with our institutional practice pattern, as it has not been shown to provide significant benefit in preventing delayed bleeding in cs-EMR for non-ampullary duodenal adenomas.8 Defect closure following cs-EMR in the duodenum is only performed in our practice if there is significant intraprocedure bleeding.Figure 3 A, Minimal bleeding observed following cold snare EMR (cs-EMR) of duodenal adenoma. B, Water immersion inspection of the area of defect following cs-EMR without evidence of residual adenoma or bleeding.

Discussion

Use of submucosal lifting solutions in EMR is effective in separating the lesion from the underlying muscularis propria. We conservatively estimate the duration of effect of the dilute epinephrine lifting solution to be 15 minutes. The addition of epinephrine in a submucosal lifting agent mixture is typically safe and well tolerated.4 There is a risk of ischemia induced by addition of epinephrine to the submucosal injectate, which has been previously described.9 This is related to the risk of increased postprocedural pain with use of epinephrine.10 This risk is likely mitigated by using a dilute concentration of epinephrine in the submucosal injectate.

Additionally, there is a theoretical risk of myocardial infarction while using large quantities of lifting agents containing epinephrine in patients with underlying cardiac risk factors.11 Although these reports are rare, these are important considerations for endoscopists to be aware of while using dilute epinephrine in submucosal lifting agents. This described technique has been used at our institution to successfully perform cs-EMR while minimizing intraprocedural oozing and aiding in effective visualization and complete resection of lesions.

Disclosure

The authors disclosed no financial relationships relevant to this publication.

Supplementary data

Video 1

Preparation and application of dilute epinephrine combined with commercially available lifting solution for cold snare endoscopic mucosal resection of duodenal adenoma.
==== Refs
References

1 Vanbiervliet G. Moss A. Arvanitakis M. Endoscopic management of superficial nonampullary duodenal tumors: European Society of Gastrointestinal Endoscopy (ESGE) Guideline Endoscopy 53 2021 522 534 33822331
2 Abdallah M. Ahmed K. Abbas D. Cold snare endoscopic mucosal resection for colon polyps: a systematic review and meta-analysis Endoscopy 55 2023 1083 1094 37451284
3 Mohamed M.F.H. Ahmed K. Rajadurai S. Efficacy and safety of cold snare endoscopic mucosal resection (CS-EMR) for nonampullary duodenal polyps: systematic review and meta-analysis J Clin Gastroenterol 58 2024 580 587 37548451
4 Tullavardhana T. Akranurakkul P. Ungkitphaiboon W. Songtish D. Efficacy of submucosal epinephrine injection for the prevention of postpolypectomy bleeding: a meta-analysis of randomized controlled studies Ann Med Surg 19 2017 65 73
5 Castro R. Libânio D. Pita I. Dinis-Ribeiro M. Solutions for submucosal injection: what to choose and how to do it World J Gastroenterol 25 2019 777 788 30809079
6 Herman T. Megna B. Pallav K. Bilal M. Endoscopic mucosal resection: tips and tricks for gastrointestinal trainees Transl Gastroenterol Hepatol 8 2023 25 37601741
7 Yandrapu H. Desai M. Siddique S. Normal saline solution versus other viscous solutions for submucosal injection during endoscopic mucosal resection: a systematic review and meta-analysis Gastrointest Endosc 85 2017 693 699 27940101
8 Wilson N. Abdallah M. Schulman A.R. Outcomes of cold snare EMR of nonampullary duodenal adenomas ≥1 cm: a multicenter study Gastrointest Endosc 99 2024 971.80.e1 38092125
9 Probst A. Maerkl B. Bittinger M. Messmann H. Gastric ischemia following endoscopic submucosal dissection of early gastric cancer Gastric Cancer 13 2010 58 61 20373077
10 Rex D.K. Lahr R.E. Peterson M.M. Vemulapalli K.C. Impact of including epinephrine in the submucosal injectate for colorectal EMR on postprocedural pain: a randomized controlled trial Gastrointest Endosc 95 2022 535 539.e1 34896443
11 Kim H.H. Park M.I. Park S.J. Moon W. Myocardial infarction thought to be provoked by local epinephrine injection during endoscopic submucosal dissection J Clin Med Res 3 2011 143 146 21811546
